Inspire Medical
INSP

From June 30, 2025 to September 30, 2025 Stock options exercised Vesting of restricted stock units and performance stock units, net Issuance of common stock Share repurchase of common stock

From March 31, 2025 to June 30, 2025 Stock options exercised Vesting of restricted stock units and performance stock units, net Issuance of common stock Issuance of common stock for employee stock purchase plan

From December 31, 2024 to March 31, 2025 Stock options exercised Vesting of restricted stock units and performance stock units, net Issuance of common stock Share repurchase of common stock Accelerated share repurchase of common stock

From December 31, 2023 to December 31, 2024 Stock options exercised, net Accelerated share repurchase of common stock Vesting of restricted stock units, net Issuance of common stock Issuance of common stock for employee stock purchase plan

From June 30, 2024 to September 30, 2024 Stock options exercised Vesting of restricted stock units Issuance of common stock Shares held for tax withholdings

From March 31, 2024 to June 30, 2024 Stock options exercised Vesting of restricted stock units Shares held for tax withholdings Issuance of common stock Issuance of common stock for employee stock purchase plan

From December 31, 2023 to March 31, 2024 Stock options exercised Shares held for tax withholdings Vesting of restricted stock units Issuance of common stock

From December 31, 2022 to December 31,2023 Stock options exercised Vesting of restricted stock units Shares held for tax withholdings Issuance of common stock Issuance of common stock for employee stock purchase plan

From June 30, 2023 to September 30, 2023 Vesting of restricted stock units Issuance of common stock Withholding taxes on net share settlement of restricted stock units Stock options exercised

From March 31, 2023 to June 30, 2023 Stock options exercised Vesting of restricted stock units Withholding taxes on net share settlement of restricted stock units Issuance of common stock Issuance of common stock for employee stock purchase plan

From December 31, 2022 to March 31, 2023 Vesting of restricted stock units Issuance of common stock Withholding taxes on net share settlement of restricted stock units Stock options exercised

From December 31, 2021 to December 31, 2022 Sale of common stock from follow-on public offering, net of offering expenses Vesting of restricted stock units Issuance of common stock Issuance of common stock for employee stock purchase plan Withholding taxes on net share settlement of restricted stock units Stock options exercised

From June 30, 2022 to September 30, 2022 Stock options exercised Sale of common stock from follow-on public offering, net of offering expenses Issuance of common stock

1.Common stock offered by 1,000,000 shares of common stock.In addition, the underwriters exercised an over-allotment of 150,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 27,634,444 shares of common stock outstanding as of June 30, 2022.

From March 31, 2022 to June 30, 2022 Issuance of common stock Issuance of common stock for employee stock purchase plan Stock options exercised

from December 31, 2021 to March 31, 2022 Stock options exercised Vesting of restricted stock units Withholding taxes on net share settlement of restricted stock units Issuance of common stock

From December 31, 2020 to December 31, 2021 Stock options exercised Issuance of common stock Issuance of common stock for employee stock purchase plan

From June 30, 2021 to September 30, 2021 Stock options exercised Issuance of common stock

From March 31, 2021 to June 30, 2021 Stock options exercised Issuance of common stock Issuance of common stock for employee stock purchase plan

from December 31, 2020 to March 31, 2021 Stock options exercised Issuance of common stock

From December 31, 2019 to December 31, 2020 Stock options exercised Issuance of common stock Sale of common stock from follow-on public offering, net of offering expenses Issuance of common stock for employee stock purchase plan

From June 30, 2020 to September 30, 2020 Stock options exercised Issuance of common stock

From March 31, 2020 to June 30, 2020 Stock options exercised Issuance of common stock Sale of common stock from follow-on public offering, net of offering expenses Issuance of common stock for employee stock purchase plan

On April 13, 2020, Inspire Medical Systems, Inc. entered into an underwriting agreement with BofA Securities, Inc., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein (collectively, the “Underwriters”), in connection with the public offering, issuance and sale by the Company of 2,000,000 shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), at a public offering price of $58.00 per share, less underwriting discounts and commissions, pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-237654) and a related prospectus supplement filed with the Securities and Exchange Commission. Under the terms of the Underwriting Agreement, the Company also granted the Underwriters an option exercisable for 30 days to purchase up to an additional 300,000 shares of its common stock at the public offering price, less underwriting discounts and commissions, which option was exercised in full prior to the closing of the offering. The closing of the offering occurred on April 16, 2020.

From December 31, 2019 to March 31, 2020 Stock options exercised Issuance of common stock

From December 31, 2018 to December 31, 2019 Stock options and warrants exercised Issuance of common stock Issuance of common stock for employee stock purchase plan

from June 30, 2019 to September 30, 2019 Stock options and warrants exercised Issuance of common stock

from December 31, 2018 to June 30, 2019 Stock options exercised Issuance of common stock Issuance of common stock for employee stock purchase plan

from December 31, 2018 to March 31, 2019 Stock options exercised Issuance of common stock

from December 31, 2017 to December 31, 2018 Stock options exercised Issuance of common stock Sale of common stock from initial public offering, net of offering expenses Sale of common stock from follow-on public offering, net of offering expenses Conversion of preferred stock to common stock

1.Common stock offered 6,750,000 shares 2.The number of shares of our common stock to be outstanding after this offering is based on 13,490,719 shares of our common stock outstanding as of March 31, 2018 3.a 1-for-6.650 reverse stock split of our common stock effected on April 20, 2018

from December 31, 2016 to December 31, 2017 Stock options exercised Sale of Series F convertible preferred stock, net issuance costs of $32 A 1-for-6.650 reverse stock split of our common stock effected on April 20, 2018